Search results

Records found: 29  
Your query: Author Sysno/Doc.kind = "^sllk_un_auth d007376 xcla^"

  1. 1.Drobné obzretia za EAACI kongresom 2017 v Helsinkách

    Drobné obzretia za EAACI kongresom 2017 v Helsinkách  / Peter Pružinec, Svetlana Hadvabová, Radovan Košturiak .  Klinická imunológia a alergológia. - ISSN 1335-0013 . - Zv. 27, č. 2 (2017), s. 38-41  : ilustr., fotogr.  
    C 2659
    article

    article

  2. 2.Effect of inulin in prevention of colon cancer development

    Effect of inulin in prevention of colon cancer development  / Hijová E. ... [et al.] .  Zborník abstraktov z 93. Fyziologických dní : 31. 1. - 2. 2. 2017, Košice, Slovenská republika . - ISBN 978-80-89046-98-0 . - S. 47  
    Z 1980
    article

    article

  3. 3.Galantamine has impact on immunity in mice exposed to keyhole limpet hemocyanin

    Galantamine has impact on immunity in mice exposed to keyhole limpet hemocyanin  / Pohanka M., Zakova J., Fusek J. .  Bratislavské lekárske listy : international journal for biomedical sciences and clinical medicine. - ISSN 0006-9248 . - Vol. 118, no. 1 (2017), s. 9-12  : ilustr., grafy, tab.  
    C 526
    article

    article

  4. 4.High TH1-type cytokine serum levels in patients with infectious mononucleosis

    High TH1-type cytokine serum levels in patients with infectious mononucleosis  / M.M. Corsi ... [et al.] .  Acta virologica : international journal. - ISSN 0001-723X . - Vol. 48, no. 4 (2004), p. 263-266  : Tab.  
    C 1035
    article

    article

  5. 5.Chemoimmunotherapy with low dose vinorelbine and interleukin-2 in treatment of patients with metastatic renal cell carcinoma

    Chemoimmunotherapy with low dose vinorelbine and interleukin-2 in treatment of patients with metastatic renal cell carcinoma  / M. P. Mencoboni ... [et al.] .  Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685 . - Vol. 53, no. 4 (2006), s. 333-336  : tab.  
    C 720
    article

    article

  6. 6.IL-15/IL-15Rα-Fc complexes provide potent stimulation of subsets of immunocompetent cells with positive role in tumor immunotherapy, but only weak stimulation of T regulatory cells

    IL-15/IL-15Rα-Fc complexes provide potent stimulation of subsets of immunocompetent cells with positive role in tumor immunotherapy, but only weak stimulation of T regulatory cells  / Petra Votavová ... [et al.] .  Klinická imunológia a alergológia. - ISSN 1335-0013 . - Zv. 21, č. 4 (2011), s. 29  
    C 2659
    article

    article

  7. 7.IL-2 immunocomplexes show significant synergistic anti-tumor effect in combination with polymerbound doxorubicin

    IL-2 immunocomplexes show significant synergistic anti-tumor effect in combination with polymerbound doxorubicin  / J. Tomala ... [et al.] .  Klinická imunológia a alergológia. - ISSN 1335-0013 . - Zv. 21, č. 4 (2011), s. 29  
    C 2659
    article

    article

  8. 8.Immunity profile in breast cancer patients

    Immunity profile in breast cancer patients  / Hrubisko M. ... [et al.] .  Bratislavské lekárske listy : international journal for biomedical sciences and clinical medicine. - ISSN 0006-9248 . - Vol. 111, no. 1 (2010), s. 20-26  : ilustr., obr., tab.  
    C 526
    article

    article

  9. 9.Imunoterapia pri karcinóme obličky

    Imunoterapia pri karcinóme obličky  / Michal Chovanec .  Onkológia. - ISSN 1336-8176 . - Roč. 11, č. 4 (2016), s. 215-217  
    C 3069
    article

    article

  10. 10.Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial

    Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial  / M. E. Gore ... [et al.] .  Onkológia. - ISSN 1336-8176 . - Roč. 6, č. 1 (2011), s. 57  
    C 3069
    article

    article


  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all